Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Third Quarter Trading Statement

27 Oct 2011 07:00

RNS Number : 9104Q
Croda International PLC
27 October 2011
 



27 October 2011

 

Croda International Plc

 

Third Quarter Trading Statement

 

Commenting on trading for the quarter ended 30 September 2011, Martin Flower, Chairman of Croda International Plc, said:

 

"I am pleased to report good turnover and profit progress in the third quarter, driven by sales growth and margin improvement in our core businesses.

 

For the three months ended 30 September 2011, Group sales from continuing operations increased 5.1% to £265.6m (2010: £252.6m). In most business areas we saw an improving trend during the quarter.

 

Operating profit from continuing operations increased 18.3% to £57.6m (2009: £48.7m). Interest costs fell, resulting in continuing pre-tax profit increasing 20.8% to £57.4m (2010: £47.5m).

Year-to-date, the pre-tax profit from continuing operations is up 27.1% at £182.2m (2010: £143.4m).

 

Consumer Care continued to trade strongly in the third quarter, reporting a significant increase in sales (+13.6%) and operating profit (+30.8%) and improved margins versus the corresponding quarter in 2010. Sales and operating profits in all business areas within Consumer Care were well ahead of 2010.

 

Industrial Specialities turnover declined 3.5% against the tough comparatives of a particularly strong third quarter in 2010. The shortfall was in July, with sales in the rest of the period ahead of 2010. Operating profit was down 6.8% with a decrease in commodity and by-product profitability being partially mitigated by stronger performances elsewhere in the sector.

 

Net debt reduced by £15.5m to £237.8m in the quarter (2010: £240.7m) despite completing the £50m buyback programme in the period.

 

Croda continues to trade well and we expect to report further progress in the final quarter and into 2012."

 

For further information please contact:

 

Mike Humphrey

Group Chief Executive

01405 860551

Sean Christie

Group Finance Director

01405 860551

Charlie Armitstead

FTI Consulting

020 7269 7176

 

 

The company will host a conference call for analysts at 8.00am today.

 

Please dial +44 (0)1452 562 815 and quote "Croda International" to gain access to the call.

 

Additional Information

 

 

 

 

 

£m

Q3

9 months

2011

2010

2011

2010

Consumer Care

145.6

128.2

+13.6%

439.2

392.6

+11.9%

Industrial Specialities

120.0

124.4

-3.5%

386.0

371.9

+3.8%

Continuing turnover

265.6

252.6

+5.1%

825.2

764.5

+7.9%

Consumer Care

42.5

32.5

+30.8%

130.5

103.6

+26.0%

Industrial Specialities

15.1

16.2

-6.8%

52.4

45.6

+14.9%

Continuing operating profit

57.6

48.7

+18.3%

182.9

149.2

+22.6%

Operating margin

 

21.6%

 

19.3%

 

 

 

22.2%

 

19.5%

 

 

 

Interest

(0.2)

(1.2)

(0.7)

(5.8)

Continuing pre tax profit

57.4

47.5

+20.8%

182.2

143.4

+27.1%

 

 

 

 

Analysis of Q3 turnover uplift

Price/mix

+18.4%

Volume

-14.8%

Currency translation

+1.5%

Continuing turnover increase

+5.1%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMFBATMBJTBIB
Date   Source Headline
11th Apr 20144:51 pmRNSDirector/PDMR Shareholding
1st Apr 20147:01 amRNSDirector Declaration
31st Mar 20141:52 pmRNSDirector/PDMR Shareholding
27th Mar 20145:17 pmRNSDirector/PDMR Shareholding
24th Mar 20145:30 pmRNSAnnual Financial Report
12th Mar 20142:16 pmRNSDirector/PDMR Shareholding
7th Mar 20143:42 pmRNSDirector/PDMR Shareholding
6th Mar 20143:33 pmRNSDirector/PDMR Shareholding
3rd Mar 20142:52 pmRNSDirector/PDMR Shareholding
25th Feb 20147:00 amRNSPreliminary Results
24th Jan 20147:00 amRNSDirectorate Change
13th Jan 20143:15 pmRNSDirector/PDMR Shareholding
11th Dec 20132:32 pmRNSDirector/PDMR Shareholding
10th Dec 20134:25 pmRNSDirector/PDMR Shareholding
28th Nov 20131:35 pmRNSHolding(s) in Company
13th Nov 20131:41 pmRNSDirector/PDMR Shareholding
13th Nov 201310:07 amRNSHolding(s) in Company
8th Nov 20139:52 amRNSDirector/PDMR Shareholding
7th Nov 20132:07 pmRNSDirector/PDMR Shareholding
5th Nov 20137:00 amRNSCapital Markets Day
1st Nov 201312:24 pmRNSDirector/PDMR Shareholding
31st Oct 20137:00 amRNSInterim Management Statement
30th Oct 20135:25 pmRNSHolding(s) in Company
11th Oct 20134:38 pmRNSDirector/PDMR Shareholding
7th Oct 20131:06 pmRNSHolding(s) in Company
4th Oct 201312:01 pmRNSDirector/PDMR Shareholding
19th Sep 20131:51 pmRNSDirector/PDMR Shareholding
11th Sep 20131:59 pmRNSDirector/PDMR Shareholding
13th Aug 201311:43 amRNSDirector/PDMR Shareholding
6th Aug 20139:27 amRNSAcquisition
5th Aug 20139:59 amRNSHolding(s) in Company
1st Aug 20132:12 pmRNSHolding(s) in Company
29th Jul 20137:00 amRNSAcquisition
26th Jul 20138:33 amRNSDirector/PDMR Shareholding
24th Jul 20132:44 pmRNSDirector/PDMR Shareholding
23rd Jul 20137:00 amRNSInterim Results 2013
17th Jul 20139:15 amRNSHolding(s) in Company
15th Jul 20133:58 pmRNSHolding(s) in Company
11th Jul 20134:43 pmRNSDirector/PDMR Shareholding
1st Jul 20139:46 amRNSHolding(s) in Company
28th Jun 20139:32 amRNSHolding(s) in Company
11th Jun 20135:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20133:57 pmRNSDirector/PDMR Shareholding
24th May 20137:00 amRNSAcquisition
22nd May 20132:58 pmRNSDirector/PDMR Shareholding
13th May 20134:35 pmRNSDirector/PDMR Shareholding
1st May 20134:30 pmRNSDirector/PDMR Shareholding
30th Apr 20134:42 pmRNSDirector/PDMR Shareholding Replacement
30th Apr 20134:16 pmRNSDirector/PDMR Shareholding
30th Apr 20138:23 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.